Novel 3′-diindolylmethane nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells

Liver cancer (LC) ranks as the second most prevalent cause of cancer-related deaths. Herbaceous plants are valuable sources of complementary, adjuvant, or alternative anti-tumor therapy as they contain natural active ingredients with anti-cancer potential. Although the clinical use of 3, 3′-Diindoly...

Full description

Bibliographic Details
Main Authors: Steve Harakeh, Saber H. Saber, Turki alamri, Rajaa Al-Raddadi, Soad Al-Jaouni, Hanaa Tashkandi, Mohammed Qari, Yousef Qari, Isaac O. Akefe, Zakariya Y. Abd Elmageed, Shafiul Haque, Anwar M Hashem, Eram Albajri, Shaker Mousa
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Journal of King Saud University: Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1018364723003269
_version_ 1797653937942167552
author Steve Harakeh
Saber H. Saber
Turki alamri
Rajaa Al-Raddadi
Soad Al-Jaouni
Hanaa Tashkandi
Mohammed Qari
Yousef Qari
Isaac O. Akefe
Zakariya Y. Abd Elmageed
Shafiul Haque
Anwar M Hashem
Eram Albajri
Shaker Mousa
author_facet Steve Harakeh
Saber H. Saber
Turki alamri
Rajaa Al-Raddadi
Soad Al-Jaouni
Hanaa Tashkandi
Mohammed Qari
Yousef Qari
Isaac O. Akefe
Zakariya Y. Abd Elmageed
Shafiul Haque
Anwar M Hashem
Eram Albajri
Shaker Mousa
author_sort Steve Harakeh
collection DOAJ
description Liver cancer (LC) ranks as the second most prevalent cause of cancer-related deaths. Herbaceous plants are valuable sources of complementary, adjuvant, or alternative anti-tumor therapy as they contain natural active ingredients with anti-cancer potential. Although the clinical use of 3, 3′-Diindolylmethane (DIM) has been established, its low chemical stability and bioavailability, limits its therapeutic applications. Increasing effort has been undertaken to improve DIM’s biological activity including nanoformulations. Here, we evaluated the efficacy of DIM nanoparticles (DIM-NPs) coated with PEG/chitosan for the treatment of liver cancer and elucidated the underlying molecular mechanisms contributing to its anti-tumor activity. DIM-PLGA-PEG/chitosan NPs were synthesized and characterized using dynamic light scattering (DLS). The effect of newly synthesized DIM-NPs was evaluated in HepG-2 and HUH-7 hepatocarcinoma cells and compared to THLE-2 immortal normal liver cells and WI-38 (normal lung fibroblast cells). These cells were treated with different non-cytotoxic concentrations of DIM-NPs and MTT assay and other functional assays were performed. Compared to normal cells, DIM-NPs induced cytotoxicity in HepG-2 cells at 6.25  µg/mL after 48 h of treatment. Treatment of HepG-2 cells with the 50 % inhibitory concentration (IC50) 12.5 µg/mL of DIM-NPs inhibited cell migration (p < 0.001). Treatment of chicken embryo with 5ug/ml DIM-NPs reduced (p < 0.001) angiogenesis at day 4. Notably, at the molecular level, DIM-NPs upregulated Bax and p53 and downregulated Bcl-2 in a dose-dependent manner. DIM-NPs also induced cell apoptosis in HepG-2 cells. Treatment of hepatic cells with DIM-NPs decreased cell proliferation, migration and angiogenesis, and induced cell death via up-regulation of Bax and p53, and down-regulation of Bcl-2 in HepG-2 cells. Further investigations are necessitated to determine the pharmacokinetics of DIM-NPs using a preclinical cancer model.
first_indexed 2024-03-11T16:52:06Z
format Article
id doaj.art-1dc8c31c920d43d1ba5d14a677343473
institution Directory Open Access Journal
issn 1018-3647
language English
last_indexed 2024-03-11T16:52:06Z
publishDate 2023-11-01
publisher Elsevier
record_format Article
series Journal of King Saud University: Science
spelling doaj.art-1dc8c31c920d43d1ba5d14a6773434732023-10-21T04:22:08ZengElsevierJournal of King Saud University: Science1018-36472023-11-01358102864Novel 3′-diindolylmethane nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cellsSteve Harakeh0Saber H. Saber1Turki alamri2Rajaa Al-Raddadi3Soad Al-Jaouni4Hanaa Tashkandi5Mohammed Qari6Yousef Qari7Isaac O. Akefe8Zakariya Y. Abd Elmageed9Shafiul Haque10Anwar M Hashem11Eram Albajri12Shaker Mousa13King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia; Yousef Abdul Latif Jameel Scientific Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; Corresponding authors at: King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia (S. Harakeh).Laboratory of Molecular Cell Biology, Department of Zoology, Faculty of Science, Assiut University, Assiut 71515, EgyptFamily and Community Medicine Department, Faculty of Medicine in Rabigh, King Abdulaziz University, Jeddah, Saudi ArabiaDepartment of Community Medicine, Faculty of Medicine, King Abdulaziz University, Saudi ArabiaYousef Abdul Latif Jameel Scientific Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Hematology/ Pediatric Oncology, King Abdulaziz University Hospital, FM, King Abdulaziz University, Jeddah, Saudi ArabiaDepartment of Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi ArabiaYousef Abdul Latif Jameel Scientific Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Hematology/ Pediatric Oncology, King Abdulaziz University Hospital, FM, King Abdulaziz University, Jeddah, Saudi ArabiaDepartment of Medicine, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi ArabiaDepartment of Physiology, Biochemistry and Pharmacology, Faculty of Veterinary Medicine, University of Jos, NigeriaDepartment of Pharmacology, Edward Via College of Osteopathic Medicine, University of Louisiana at Monroe, Monroe, LA 71203, USAResearch and Scientific Studies Unit, College of Nursing and Allied Health Sciences, Jazan University, Jazan 45142, Saudi Arabia; Bursa Uludağ University Faculty of Medicine, Görükle Campus, 16059 Nilüfer, Bursa, TurkeyDepartment of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia; Vaccine and Immunotherapy Unit, King Fahd Medical Research Center, Jeddah 21589, Saudi ArabiaClinical Nutrition Department, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi ArabiaPharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA; Corresponding authors at: King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia (S. Harakeh).Liver cancer (LC) ranks as the second most prevalent cause of cancer-related deaths. Herbaceous plants are valuable sources of complementary, adjuvant, or alternative anti-tumor therapy as they contain natural active ingredients with anti-cancer potential. Although the clinical use of 3, 3′-Diindolylmethane (DIM) has been established, its low chemical stability and bioavailability, limits its therapeutic applications. Increasing effort has been undertaken to improve DIM’s biological activity including nanoformulations. Here, we evaluated the efficacy of DIM nanoparticles (DIM-NPs) coated with PEG/chitosan for the treatment of liver cancer and elucidated the underlying molecular mechanisms contributing to its anti-tumor activity. DIM-PLGA-PEG/chitosan NPs were synthesized and characterized using dynamic light scattering (DLS). The effect of newly synthesized DIM-NPs was evaluated in HepG-2 and HUH-7 hepatocarcinoma cells and compared to THLE-2 immortal normal liver cells and WI-38 (normal lung fibroblast cells). These cells were treated with different non-cytotoxic concentrations of DIM-NPs and MTT assay and other functional assays were performed. Compared to normal cells, DIM-NPs induced cytotoxicity in HepG-2 cells at 6.25  µg/mL after 48 h of treatment. Treatment of HepG-2 cells with the 50 % inhibitory concentration (IC50) 12.5 µg/mL of DIM-NPs inhibited cell migration (p < 0.001). Treatment of chicken embryo with 5ug/ml DIM-NPs reduced (p < 0.001) angiogenesis at day 4. Notably, at the molecular level, DIM-NPs upregulated Bax and p53 and downregulated Bcl-2 in a dose-dependent manner. DIM-NPs also induced cell apoptosis in HepG-2 cells. Treatment of hepatic cells with DIM-NPs decreased cell proliferation, migration and angiogenesis, and induced cell death via up-regulation of Bax and p53, and down-regulation of Bcl-2 in HepG-2 cells. Further investigations are necessitated to determine the pharmacokinetics of DIM-NPs using a preclinical cancer model.http://www.sciencedirect.com/science/article/pii/S10183647230032693, 3′-Diindolylmethane (DIM) nanoparticlesHepatic cancer cellsMigrationAngiogenesisApoptosis
spellingShingle Steve Harakeh
Saber H. Saber
Turki alamri
Rajaa Al-Raddadi
Soad Al-Jaouni
Hanaa Tashkandi
Mohammed Qari
Yousef Qari
Isaac O. Akefe
Zakariya Y. Abd Elmageed
Shafiul Haque
Anwar M Hashem
Eram Albajri
Shaker Mousa
Novel 3′-diindolylmethane nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells
Journal of King Saud University: Science
3, 3′-Diindolylmethane (DIM) nanoparticles
Hepatic cancer cells
Migration
Angiogenesis
Apoptosis
title Novel 3′-diindolylmethane nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells
title_full Novel 3′-diindolylmethane nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells
title_fullStr Novel 3′-diindolylmethane nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells
title_full_unstemmed Novel 3′-diindolylmethane nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells
title_short Novel 3′-diindolylmethane nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells
title_sort novel 3 diindolylmethane nanoformulation induces apoptosis and reduces migration and angiogenesis in liver cancer cells
topic 3, 3′-Diindolylmethane (DIM) nanoparticles
Hepatic cancer cells
Migration
Angiogenesis
Apoptosis
url http://www.sciencedirect.com/science/article/pii/S1018364723003269
work_keys_str_mv AT steveharakeh novel3diindolylmethanenanoformulationinducesapoptosisandreducesmigrationandangiogenesisinlivercancercells
AT saberhsaber novel3diindolylmethanenanoformulationinducesapoptosisandreducesmigrationandangiogenesisinlivercancercells
AT turkialamri novel3diindolylmethanenanoformulationinducesapoptosisandreducesmigrationandangiogenesisinlivercancercells
AT rajaaalraddadi novel3diindolylmethanenanoformulationinducesapoptosisandreducesmigrationandangiogenesisinlivercancercells
AT soadaljaouni novel3diindolylmethanenanoformulationinducesapoptosisandreducesmigrationandangiogenesisinlivercancercells
AT hanaatashkandi novel3diindolylmethanenanoformulationinducesapoptosisandreducesmigrationandangiogenesisinlivercancercells
AT mohammedqari novel3diindolylmethanenanoformulationinducesapoptosisandreducesmigrationandangiogenesisinlivercancercells
AT yousefqari novel3diindolylmethanenanoformulationinducesapoptosisandreducesmigrationandangiogenesisinlivercancercells
AT isaacoakefe novel3diindolylmethanenanoformulationinducesapoptosisandreducesmigrationandangiogenesisinlivercancercells
AT zakariyayabdelmageed novel3diindolylmethanenanoformulationinducesapoptosisandreducesmigrationandangiogenesisinlivercancercells
AT shafiulhaque novel3diindolylmethanenanoformulationinducesapoptosisandreducesmigrationandangiogenesisinlivercancercells
AT anwarmhashem novel3diindolylmethanenanoformulationinducesapoptosisandreducesmigrationandangiogenesisinlivercancercells
AT eramalbajri novel3diindolylmethanenanoformulationinducesapoptosisandreducesmigrationandangiogenesisinlivercancercells
AT shakermousa novel3diindolylmethanenanoformulationinducesapoptosisandreducesmigrationandangiogenesisinlivercancercells